Home/Filings/4/0001128732-16-000018
4//SEC Filing

Sunshine Biopharma, Inc 4

Accession 0001128732-16-000018

$SBFMCIK 0001402328operating

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 8:49 AM ET

Size

6.3 KB

Accession

0001128732-16-000018

Insider Transaction Report

Form 4
Period: 2016-04-12
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
  • Award

    Common Stock

    2016-04-22$0.01/sh+12,000,000$84,00012,384,373 total
  • Purchase

    Common Stock

    2016-04-12$0.20/sh+253,082$50,00930,570,776 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)

Issuer

Sunshine Biopharma, Inc

CIK 0001402328

Entity typeoperating
IncorporatedCO

Related Parties

1
  • filerCIK 0001402328

Filing Metadata

Form type
4
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 8:49 AM ET
Size
6.3 KB